Back Login for AI Analysis

    RARE (STOCKS)

    Ultragenyx Pharmaceutical Inc.

    $14.949400
    +0.029400 (+0.20%)
    Prev close: $14.920000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Emil D. Kakkis
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $1,469.96M
    Employees
    1,294
    P/E (TTM)
    -2.55
    P/B (TTM)
    -5.03
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    9
    Strong Buy
    14
    Buy
    3
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    		 $-0.90 $-1.24 +0.3395 +27.39%
    Mar 2026 (Q1)
    		 $-1.84 $-1.54 -0.3001 -19.49%
    Dec 2025 (Q4)
    		 $-1.29 $-1.11 -0.1762 -15.82%
    Sep 2025 (Q3)
    		 $-1.81 $-1.26 -0.5508 -43.74%